+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Genentech, Inc.  - logo

Genentech, Inc., a biotechnology company, engages in the research, development, manufacture, and marketing of biotechnology products for treating patients with serious or life-threatening diseases in the United States. It offers molecular entities and medicines in the areas of oncology, immunology, neuroscience, metabolism, and infectious diseases. The company was founded in 1976 and is headquartered in South San Francisco, California. Genentech operates as a subsidiary of Roche Holdings, Inc.

Alpha4beta7 Integrin Antagonists - Pipeline Insight, 2025 - Product Thumbnail Image

Alpha4beta7 Integrin Antagonists - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
From
Progressive Supranuclear Palsy- Pipeline Insight, 2025 - Product Thumbnail Image

Progressive Supranuclear Palsy- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
XOLAIR Marketed Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

XOLAIR Marketed Drug Insight and Market Forecast - 2032

  • Report
  • September 2022
  • 30 Pages
  • Global
From
From
From
Human Growth Hormone Market Report and Forecast 2023-2031 - Product Thumbnail Image

Human Growth Hormone Market Report and Forecast 2023-2031

  • Report
  • July 2023
  • 140 Pages
  • Global
From
CD 3 Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

CD 3 Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 90 Pages
  • Global
From
Vestibular Schwannoma - Pipeline Insight, 2025 - Product Thumbnail Image

Vestibular Schwannoma - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 50 Pages
  • Global
From
From
From
Chronic Spontaneous Urticaria (CSU) - Epidemiology Forecast - 2032 - Product Thumbnail Image

Chronic Spontaneous Urticaria (CSU) - Epidemiology Forecast - 2032

  • Drug Pipelines
  • January 2022
  • 100 Pages
  • Global
From
Anti-CD274 (PD-L1) Antibody - Pipeline Insight, 2025 - Product Thumbnail Image

Anti-CD274 (PD-L1) Antibody - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 90 Pages
  • Global
From
Anti-CD3 Antibody - Pipeline Insight, 2025 - Product Thumbnail Image

Anti-CD3 Antibody - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 90 Pages
  • Global
From
From
Loading Indicator